Article Details
Retrieved on: 2021-06-22 15:11:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
In an analysis comparing ZUMA-5 patients with a minimum of 18 months follow-up with those observed in SCHOLAR-5, axicabtagene ciloleucel showed ...
Article found on: www.pharmacytimes.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here